Exelixis (EXEL) Q2 2022 Earnings Call Transcript

Exelixis (EXEL) Q2 2022 Earnings Call Transcript
·46 min read

Thank you, Sarah, and thank you all for joining us for the Exelixis second quarter 2022 financial results conference call. Joining me on today's call are Mike Morrissey, our president and CEO; Chris Senner, our chief financial officer; P.J. Haley, our executive vice president of commercial; Vicki Goodman, our chief medical officer; and Peter Lamb, our chief scientific officer, who will together review our progress for the second quarter 2022 ended June 30th, 2022.